Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-22-029551
Filing Date
2022-08-16
Accepted
2022-08-16 07:38:06
Documents
6
Period of Report
2022-08-15

Document Format Files

Seq Description Document Type Size
1 6-K meso-6k_20220811.htm 6-K 24542
2 EX-99.1 meso-ex991_6.htm EX-99.1 29292
3 GRAPHIC gdhjpzbz0ywu000002.jpg GRAPHIC 10298
4 GRAPHIC gdhjpzbz0ywu000003.jpg GRAPHIC 202825
5 GRAPHIC gi4dnxgt343c000001.jpg GRAPHIC 631
6 GRAPHIC gdhjpzbz0ywu000001.jpg GRAPHIC 5399
  Complete submission text file 0001564590-22-029551.txt   357205
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 221168507
SIC: 2836 Biological Products, (No Diagnostic Substances)